Frailty and the Risk of Falls in HIV- Infected Older Adults in the ACTG A5322 Study

Similar documents
Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults

Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women

HIV, Aging, and Frailty: Cannonball?

Clinical Epidemiology of Frailty in HIV Infection. Joseph B. Margolick, MD, PhD Johns Hopkins Bloomberg School of Public Health

Physical Function & Frailty in HIV

Prevalence of Comorbidities among HIV-positive patients in Taiwan

HIV and Aging: Impact on CD4 Gains, Frailty, Falls, Cognition, and MIs

Mitochondrial DNA variation associated with gait speed decline among older HIVinfected non-hispanic white males

Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case-control study

Alysa Krain MD, MSc. March 7, 2018

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

Deborah Kacanek, Konstantia Angelidou, Paige L. Williams, Miriam Chernoff, Kenneth Gadow, Sharon Nachman, The IMPAACT P1055 Study Team

3rd IAS Conference on HIV Pathogenesis and Treatment. Poster Number Abstract #

Repeat Pregnancies and HIV Care Engagement among Postpartum HIV-infected Women in Atlanta, Georgia,

Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi

PIs are the real world answer for the chronic patient s management. Giovanni Guaraldi

Contact Author: Running Head: Disability in HIV

Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection

Supplementary Online Content

Increased and accelerated age-related complications in HIV-infected patients

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral- Naive HIV-Infected Subjects

Sexual dysfunction in an aging HIV positive population compared to HIV negative control groups. Results from the German 50/2010 cohort study

Introduction to HIV and Aging

Study setting. Background and objectives. Associations between sleep parameters,

Risk Factors for Falls in HIV-Infected Persons

Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS

ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE & CONTEMPORARILY USED PROTEASE INHIBITORS

Report Back from CROI 2010

HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings

Binge drinking decreases weekend adherence in a RCT from low and middle income countries

PART IV! CLINICAL IMPLICATIONS

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

C E L I A J. M A X W E L L, M. D

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

Evaluation of Asthma Management in Middle EAst North Africa Adult population

Obesity and Control. Body Mass Index (BMI) and Sedentary Time in Adults

BHIVA Best of CROI Feedback Meetings. London Birmingham North West England Cardiff Gateshead Edinburgh

Future challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study

HIV-1 Dual Infection and Neurocognitive Impairment

Journal of Infectious Diseases Advance Access published March 23, CD28-Negative CD4+ and CD8+ T-cells in ART-Naive HIV-Infected Adults

Supplementary Online Content

CD4 nadir and antiretroviral exposure predict premature polypathology onset

Metabolic Syndrome is Associated with Neurocognitive Deficits in Persons Living with HIV

Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort

Dispelling the myths: HIV, ageing and the changing causes of morbidity Caroline A Sabin

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference

Measles, Mumps and Rubella Seropositivity in Children with Perinatal HIV Infection

Frailty and HIV: what is the evidence? Giovanni Guaraldi

Implementing frailty into clinical practice:

Hormonal Contraception Use and Non-AIDSdefining

Optimizing Health While Aging with HIV

Didactic Series. Bone Health in the context of HIV. Christian B. Ramers, MD, MPH, AAHIVS Family Health Centers of San Diego 9/22/16

MIRT Program ABSTRACTS 2011

Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection

HPTN 061: The Brothers Study

11/7/2012. HIV disease: Chronic Disease Patients are aging with their HIV disease on effective antiretroviral therapy (ART)

Evaluating an enhanced adherence intervention among HIV positive adolescents failing 2 nd line treatment

Multisystem Impairment in Perinatally HIV-infected (PHIV) South African Adolescents

Supplemental materials for:

Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus

INTERNATIONAL WORKSHOP ON HIV PEDIATRICS - JULY

Harvard University Center for AIDS Research Non-Communicable Diseases Scientific Working Group JANUARY 10, 2017 DATA HARMONIZATION WORKSHOP

No Conflict of Interest

Integrating Geriatrics into Oncology Care

HIV and the Aging Patient: Managing Co-morbidities. Heather Free, PharmD, AAHIVP

Assessing frailty in the community: experience from t he Lc65+ st udy Progetto strategico "E-health Strate kega projekta "E-heath"

Smoking Status and Body Mass Index in the United States:

Is there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents?

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS

Dr Paddy Mallon. Mater Misericordiae University Hospital, Dublin, Ireland. BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions

The Deconditioned Elderly Patient: Have We Been Getting it Wrong? By: Ernest Roy PT, DPT

Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa

ADHERENCE TRAJECTORIES AMONG AFRICAN AMERICANS LIVING WITH HIV

Depression in People Living with HIV/AIDS: Outcomes, Risks and Opportunities for Intervention

Caring for the ageing HIV infected patients: meeting the challenge

Frailty: from Academic Definition to Clinical Applicability

The Association Between Cystatin C and Frailty Status in Older Men

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Supplementary Online Content

Wellness Coaching for People with Prediabetes

Carolyn J. Crandall, MD, MS On behalf of the WHI Bone SIG

A n aly tical m e t h o d s

HIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital

Secondary analyses of HSE data and linked health outcomes - an overview of work in progress. UCL (University College London)

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example

Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy

Treatment experience in South Africa. Dr Ian Sanne Clinical HIV Research Unit University of the Witwatersrand

Supplementary Online Content

J.Y. WANG 1, A.C. TSAI 1,2

36-Item Short Form Survey (SF-36) Versus Gait Speed as a Predictor of Preclinical Mobility Disability in Older Women

Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes

IAPAC 11 th International Conference on HIV Treatment and Prevention Adherence Fort Lauderdale, FL May 11, 2016

Preoperative Assessment Guidelines in the Elderly

Physical activity, physical fitness and body composition of Canadian shift workers

ESCMID Online Lecture Library. by author

Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand

Transcription:

Frailty and the Risk of Falls in HIV- Infected Older Adults in the ACTG A5322 Study Katherine Tassiopoulos, Mona Abdo, Susan L. Koletar, Frank Palella, Babafemi Taiwo, and Kristine M. Erlandson for the A5322 Team The A5322 (HAILO) Study

Background/Rationale Falls are a significant risk factor for healthrelated complications and mortality in the general population (Rubenstein et al, Age and Ageing 2006) Falls may occur at younger ages among HIVinfected individuals compared to the general population (Erlandson et al, JAIDS 2012) Falls are common in HIV-infected adults; recent studies show 20% with 1 fall in 12-month period (Erlandson, JAIDS 2012; Erlandson, HIV Med 2016; WIHS presentation)

Background/Rationale As HIV-infected adults age, frailty will also become a more prevalent problem (Brothers et al, JID 2014) Studies of the association between frailty (particularly pre-frailty) and falls in the context of HIV infection are limited N=359 HIV+ men and women: For frail vs non-frail individuals, the OR for recurrent falls was 9.5 (95% CI=3.6, 25.1)(Erlandson, 2012)

Background/Rationale AGEhIV Cohort Study: Frailty but not pre-frailty predicted 1 fall over one year follow-up (Kooij et al, EACS [European AIDS Clinical Society] Conference 2015)

A5322/HAILO The AIDS Clinical Trials Group (ACTG) protocol A5322 (HAILO) is a longitudinal cohort study of 1035 HIV-infected adults 40 years or older at enrollment Received their initial ART regimen through an ACTG clinical trial Subsequently followed long-term in ACTG observational study A5001

A5322/HAILO Research visits take place every 6 months Every 6 months Medical chart abstraction Medication review Falls interview Yearly Body measurements Laboratory tests Frailty assessment Questionnaires (Cigarettes/drugs/alcohol, sexual behavior, insurance, instrumental activities of daily living) Neurocognitive evaluation Repository specimens (plasma/serum every 6 mos, PBMC every 2 yrs)

Frailty Assessment Fried s Frailty assessment - 5 components: 1. 4-meter walk speed 2. Grip strength 3. Self-reported unintentional weight loss ( 10 lbs) in past year 4. Self-reported exhaustion Experiencing 3-4 times/week that everything I do is an effort or sometimes I just cannot get going 5. Self-reported low physical activity levels Limited a lot" in response to Short Form (SF)-36 question, "does your health limit you in vigorous activities such as running, lifting heavy objects, or participating in strenuous sports?"

Falls Assessment Falls questionnaire administered every 6 months Any falls in past 6 months? If yes: How many? (1, 2, 3-5, 6+) Required medical attention? Resulted in broken bone(s)?

Objectives 1. Identify number of HAILO participants with any falls (1+) and recurrent falls (2+) over 12 month period, and proportion of falls resulting in medical treatment or fracture 2. Examine association between frailty status and incidence of single and recurrent falls

Methods: Study Population All HAILO participants who completed frailty assessment at entry visit and 1 falls interview over the next year

Methods Exposure Primary exposure: 3- category frailty variable Frail = 3 of 5 components Pre-frail = 1-2 components Non-frail = 0 components Individual frailty components also examined Slow 4-m walk speed (>4 seconds) Weak grip strength (sexspecific cutoffs) Outcome Any falls over one year period Single and recurrent (2+) falls over one year period

Methods: Potential Confounders Demographic Age Sex Race/ethnicity Education Clinical/Medical Health insurance BMI Waist circumference Hypertension medication Depression/anxiety medication Co-morbidities (diabetes, hypertension, HCV, CVD, kidney or liver disease, cancer) Behavioral Physical activity Alcohol use Substance use Cigarette smoking HIV-Disease Specific Peripheral neuropathy Didanosine/stavudine use AIDS-defining condition

Methods: Statistical Analyses Multinomial logistic regression to assess the association between frailty (and weak grip, slow walk speed) and falls (single and recurrent falls) Each potential confounder added one at a time to univariable model Variables that changed effect estimate by 15% kept in final, multivariable model

Results: Study Population Characteristics Entry Characteristics N=967 Median (Q1, Q3) age, years 51 (46-56) Female 19% White, non-hispanic 48% HIV-1 RNA <50 copies/ml 92% CD4 count (cells/mm 3 ) 500 501-700 > 700 32% 28% 40%

Results: Occurrence of Falls All Participants N=967 Participants with any (1+) falls over 12 months 174 (18.0%) Participants with recurrent (2+) falls 68 (7.0%) Participants with 1+ Falls N=174 Sought medical attention for fall 36 (20.7%) Fall resulted in fracture 9 (5.2%)

Results: Falls by Age 25.8% 20.7% 12.7% P-value = 0.0003

Results: Falls by Frailty Status 49.2% 21.5% 12.2% P-value <0.0001

Results: Multivariable Associations between Frailty Measures and Falls Frailty and pre-frailty associated with both single and recurrent falls Slow walk speed and weak grip associated with recurrent falls only Frailty-Falls models adjusted for: age, race/ethnicity, alcohol use, neuroscreen score Walk-Falls models adjusted for: age, race/ethnicity, alcohol use, neuroscreen score, health insurance, education Grip-walk models adjusted for: age, race/ethnicity, alcohol use, substance use, physical activity, diabetes, and health insurance

Summary Aging HIV-infected pre-frail and frail individuals are at significantly increased risk of falls Individual components of frailty assessment may be useful predictors of recurrent falls Incorporation of frailty assessments or simple assessments of 4-m walk or grip strength in the clinical setting may help identify older HIVinfected individuals at increased risk for falls and persons who would benefit from falls prevention interventions

Acknowledgements The A5322 / HAILO Participants, Sites and Study Team The AIDS Clinical Trials Network NIAID AI 036219 and U01AI068636